QIAGEN Posts 2016 Annual Report on Its Website

Venlo the Netherlands (ots) - QIAGEN N.V. (Nasdaq: QGEN)
(Frankfurt: QIA) has posted its 2016 Annual Report on its website at
http://ots.de/YwER5. QIAGEN's Annual Report on Form 20-F for the year
ended December 31, 2016 has been filed with the U.S. Securities and
Exchange Commission (SEC) on March 3, 2017, a copy of which can be
found on the website of the SEC at www.sec.gov or in the 'Financial
Information' section of the 'Investors' section of our website at
http://www.qiagen.com/About-Us/Investors/. QIAGEN will provide
printed copies of the 2016 Annual Report to shareholders free of
charge upon request. To obtain a printed copy of the 2016 Annual
Report please contact: [e-mail].

About QIAGEN

QIAGEN N.V., a Netherlands-based holding company, is the leading
global provider of Sample to Insight solutions to transform
biological materials into valuable molecular insights. QIAGEN sample
technologies isolate and process DNA, RNA and proteins from blood,
tissue and other materials. Assay technologies make these
biomolecules visible and ready for analysis. Bioinformatics software
and knowledge bases interpret data to report relevant, actionable
insights. Automation solutions tie these together in seamless and
cost-effective molecular testing workflows. QIAGEN provides these
workflows to more than 500,000 customers around the world in
Molecular Diagnostics (human healthcare), Applied Testing (forensics,
veterinary testing and food safety), Pharma (pharmaceutical and
biotechnology companies) and Academia (life sciences research). As of
December 31, 2016, QIAGEN employed approximately 4,700 people in over
35 locations worldwide. Further information can be found at
www.qiagen.com.

Originaltext: Qiagen N.V.
digital press kits: http://www.presseportal.de/nr/76066
press kits via RSS: http://www.presseportal.de/rss/pm_76066.rss2
ISIN: NL0012169213

Contact:
Investor Relations
[e-mail]

John Gilardi
Vice President, Head of Corporate Communications and Investor
Relations
19300 Germantown Road | Germantown MD 20874 USA
Phone [phone] | Fax [phone]
QIAGEN-Str. 1 | 40724 Hilden Germany
Phone [phone] | Fax [phone]


Dr. Sarah Fakih
Associate Director Investor Relations
QIAGEN GmbH | QIAGEN-Str. 1 | 40724 Hilden | Germany
Phone [phone] | Fax [phone]